Advanced Oncotherapy (AVO) today announced a prospective recapitalisation and funding plan to raise up to £110m. Earlier this month, the company’s shares were suspended from trading on AIM after talks to raise an additional £8m in funding collapsed. The new prospective recapitalisation plan is still in its early stages but the Board said it was ‘hopeful’…
©2023 All rights reserved LaingBuisson 
 today announced a prospective recapitalisation and funding plan to raise up to £110m.){kind=link}